196 related articles for article (PubMed ID: 22266466)
1. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.
Hsieh TC; Yang CJ; Lin CY; Lee YS; Wu JM
Carcinogenesis; 2012 Mar; 33(3):670-7. PubMed ID: 22266466
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
Hsieh TC
Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
[TBL] [Abstract][Full Text] [Related]
3. In silico and biochemical analyses identify quinone reductase 2 as a target of piceatannol.
Hsieh TC; Bennett DJ; Lee YS; Wu E; Wu JM
Curr Med Chem; 2013; 20(33):4195-202. PubMed ID: 23992305
[TBL] [Abstract][Full Text] [Related]
4. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2.
Hsieh TC; Lin CY; Bennett DJ; Wu E; Wu JM
PLoS One; 2014; 9(6):e101070. PubMed ID: 24968355
[TBL] [Abstract][Full Text] [Related]
6. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
[TBL] [Abstract][Full Text] [Related]
8. Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells.
Ichikawa M; Sowa Y; Iizumi Y; Aono Y; Sakai T
PLoS One; 2015; 10(6):e0129851. PubMed ID: 26121043
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
[TBL] [Abstract][Full Text] [Related]
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
[TBL] [Abstract][Full Text] [Related]
11. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells.
Vergara D; Simeone P; Toraldo D; Del Boccio P; Vergaro V; Leporatti S; Pieragostino D; Tinelli A; De Domenico S; Alberti S; Urbani A; Salzet M; Santino A; Maffia M
Mol Biosyst; 2012 Apr; 8(4):1078-87. PubMed ID: 22234583
[TBL] [Abstract][Full Text] [Related]
13. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
[TBL] [Abstract][Full Text] [Related]
14. GSK-3beta-dependent destabilization of cyclin D1 mediates replicational stress-induced arrest of cell cycle.
Mukherji A; Janbandhu VC; Kumar V
FEBS Lett; 2008 Apr; 582(7):1111-6. PubMed ID: 18328826
[TBL] [Abstract][Full Text] [Related]
15. GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.
Dal Col J; Dolcetti R
Cell Cycle; 2008 Sep; 7(18):2813-6. PubMed ID: 18769147
[TBL] [Abstract][Full Text] [Related]
16. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
Wang CD; Yuan CF; Bu YQ; Wu XM; Wan JY; Zhang L; Hu N; Liu XJ; Zu Y; Liu GL; Song FZ
Asian Pac J Cancer Prev; 2014; 15(2):769-73. PubMed ID: 24568493
[TBL] [Abstract][Full Text] [Related]
17. PCB-153 exposure coordinates cell cycle progression and cellular metabolism in human mammary epithelial cells.
Venkatesha VA; Kalen AL; Sarsour EH; Goswami PC
Toxicol Lett; 2010 Jul; 196(2):110-6. PubMed ID: 20394812
[TBL] [Abstract][Full Text] [Related]
18. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
Chen B; Pan H; Zhu L; Deng Y; Pollard JW
Mol Endocrinol; 2005 Aug; 19(8):1978-90. PubMed ID: 15845746
[TBL] [Abstract][Full Text] [Related]
19. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
Radu A; Neubauer V; Akagi T; Hanafusa H; Georgescu MM
Mol Cell Biol; 2003 Sep; 23(17):6139-49. PubMed ID: 12917336
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.
Lo RK; Kwong YL
Ann Hematol; 2014 Feb; 93(2):255-65. PubMed ID: 23949314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
